18 Articles
18 Articles
BioNTech closes the sites for vaccine production in Germany. There is criticism. There are even harsh allegations of "tricks".
Curevac founder Ingmar Hoerr accuses Biontech of deception after the takeover. Background are site closures and job losses.
After the announced closure of BioNTech's production facilities in Germany, there is a warning of potential bottlenecks. The CureVac founder and the union are also critical.
The vaccine manufacturer Biontech has taken over his competitor Curevac. Now sites are to be closed. That makes for criticism.
Following the announcement of the vaccine manufacturer Biontech to close several sites, the founder of the biotech company Curevac is criticising.
Shortly after the acquisition, BioNTech announces that it will close the former sites of CureVac. CureVac founder Hoerr finds the »unlauter« and speaks of »trickness«.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium














